Dr. Bassem Saleh new Chief Executive Officer of TFS
The Board of Directors of TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, appointed Dr. Bassem Saleh as Chief Executive Officer, effective 17 December 2019. He will succeed Dr. János Filakovský who has led TFS for the last two years positioning the company for a long term growth. Dr. Bassem Saleh has been with TFS since 2017, as the Chief Medical Officer and EVP of Clinical Development Services. Before joining TFS, Dr. Saleh held senior leadership positions and played an integral part in the growth and success of large and mid-size